Influenza News and Research

Latest Influenza News and Research

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

University of Michigan researchers have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli, according to a study published today in the American Journal of Roentgenology.

15 Oct 2009

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

BioTech Medics, Inc. announces that it has received independent clinical testing results of its SHBAN™ Hand Sanitizer Solution to prove SHBAN™ kills the H1N1 (Swine) Influenza A virus.

15 Oct 2009

Hospital visitation policy to reduce the spread of H1N1 flu

Due to the severity of the H1N1 flu and its potential to spread to patients, children and expectant mothers, Lucile Packard Children’s Hospital and Stanford Hospital & Clinics announced today that effective Monday, October 19, 2009, both hospitals will no longer allow non-patient visitors or family members under the age of 16 inside the hospitals.

15 Oct 2009

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

The National Institutes of Health has awarded a $15.7 million contract to UT Southwestern Medical Center and Northrop Grumman Corp. to develop an open-access national online database and analysis resource center that will help scientists study and combat viruses such as those that cause hepatitis, encephalitis, smallpox, acute respiratory distress and dengue fever, as well as newly emerging pathogenic viruses.

15 Oct 2009

Human populations may have some level of existing immunity to the pandemic H1N1 influenza, say researchers

University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years. These molecular sites appear to result in some level of immunity to the new virus in people who were exposed to the earlier influenza viruses.

15 Oct 2009

Required flu vaccines for New York health workers draws criticism

The New York Civil Liberties Union is criticizing a regulation that requires hundreds of thousands of state health workers to get both seasonal and swine flu vaccinations. Critics say it violates workers' right to decide their own medical treatment.

15 Oct 2009

Government of Canada to support H1N1 flu virus research

The Government of Canada through the Canadian Institutes of Health Research (CIHR) today announced support for five new research projects designed to help further understand and address the H1N1 flu virus.

15 Oct 2009

Interim data from Sanofi Pasteur's Influenza A 2009 Monovalent Vaccine clinical trials in infants and children

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months through 9 years of age. The data indicate the vaccine is immunogenic and that one dose may protect many children.

15 Oct 2009

Surveillance of travel-related illness helps to detect and respond to H1N1 influenza

Because pandemics unfold in unpredictable ways, surveillance of travel-related illness is among the most powerful tools health officials and doctors can use to detect and respond to new pathogens like the novel H1N1 influenza, says the physician who heads the University of Alabama at Birmingham (UAB) Travelers' Clinic.

15 Oct 2009

Atlantic examines flu vaccine, antiviral skepticism

As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, "[W]hat if everything we think we know about fighting influenza is wrong?"

15 Oct 2009

Richmont Sciences to market PURE’s antimicrobial SDC disinfectants

PURE Bioscience announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE’s revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.

14 Oct 2009

Patients who are severely ill with H1N1 are at risk for developing PE, says study

Researchers utilizing computed tomography (CT) scans have found that patients with severe cases of the H1N1 virus are at risk for developing severe complications, including pulmonary emboli (PE), according to a study to be published online Oct. 14, 2009, in the American Journal of Roentgenology. The study will be published in the December issue of the AJR.

14 Oct 2009

DIATHERIX Laboratories granted EUA for H1N1-09 Influenza Test

DIATHERIX Laboratories, Inc. is pleased to announce it has been granted emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its DIATHERIX H1N1-09 Influenza Test.

14 Oct 2009

Sinovac Biotech announces receipt of Panflu vaccine distribution approval in Hong Kong

Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that its wholly-owned subsidiary, Sinovac Biotech (Hong Kong) Ltd, has received the Certificate of Approval to distribute Panflu(TM) (H5N1), its H5N1 (bird flu) pandemic influenza vaccine, in Hong Kong. The certificate is valid through September 13, 2014 and thereafter will be renewable for periods of five years at a time, subject to payment of the registration fee.

14 Oct 2009

Nobilon initiates a clinical Proof of Concept trial with SCH 900795 vaccine

Nobilon, the human vaccine business unit of Schering-Plough Corporation (NYSE: SGP), today announced that it has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.

14 Oct 2009

Inovio Biomedical's proprietary DNA vaccine development platform introduced

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, president and CEO, presented at the invitation-only World Knowledge Forum being held in Seoul, South Korea.

14 Oct 2009

Imaging as a tool to identify severe cases of H1N1

Researchers at the National Institutes of Health (NIH) have found that imaging can now be used as a tool for identifying severe cases of H1N1 and may play a key role in understanding the pathogenesis of the virus, possibly leading to earlier diagnoses of severe cases in the future, according to a study published online today in the American Journal of Roentgenology. The study will be published in the December issue of AJR.

14 Oct 2009

H1N1 patients with ARDS survive illness when treated with ECMO

Despite the severity of disease and the intensity of treatment, most patients in Australia and New Zealand who experienced respiratory failure as a result of 2009 influenza A(H1N1) and were treated with a system that adds oxygen to the patient's blood survived the disease, according to a study to appear in the November 4 issue of JAMA.

14 Oct 2009

Statewide H1N1 Vaccine Provider Registration System from Upp Technology

Supporting directives from the U.S. Centers for Disease Control and Prevention, Upp Software, a business unit of Upp Technology, Inc., has developed, delivered and now offers a Statewide H1N1 Vaccine Provider Registration System to accommodate thousands of vaccine providers' ordering and reporting needs.

14 Oct 2009

NanoBio to receive a $4.1M subcontract for developing nanoemulsion-based mucosal vaccine adjuvants

NanoBio Corporation today announced an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to fund vaccine research associated with “Innate Immune Receptors and Adjuvant Discovery.” NanoBio is the principal subcontractor for the $9.3 million contract awarded to the University of Michigan.

14 Oct 2009

Influenza News and Research

Latest Influenza News and Research

Patients with severe cases of the H1N1 virus are at risk for developing severe complications

BioTech Medics' SHBAN Hand Sanitizer Solution kills H1N1 Influenza A virus

Hospital visitation policy to reduce the spread of H1N1 flu

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

Human populations may have some level of existing immunity to the pandemic H1N1 influenza, say researchers

Required flu vaccines for New York health workers draws criticism

Government of Canada to support H1N1 flu virus research

Interim data from Sanofi Pasteur's Influenza A 2009 Monovalent Vaccine clinical trials in infants and children

Surveillance of travel-related illness helps to detect and respond to H1N1 influenza

Atlantic examines flu vaccine, antiviral skepticism

Richmont Sciences to market PURE’s antimicrobial SDC disinfectants

Patients who are severely ill with H1N1 are at risk for developing PE, says study

DIATHERIX Laboratories granted EUA for H1N1-09 Influenza Test

Sinovac Biotech announces receipt of Panflu vaccine distribution approval in Hong Kong

Nobilon initiates a clinical Proof of Concept trial with SCH 900795 vaccine

Inovio Biomedical's proprietary DNA vaccine development platform introduced

Imaging as a tool to identify severe cases of H1N1

H1N1 patients with ARDS survive illness when treated with ECMO

Statewide H1N1 Vaccine Provider Registration System from Upp Technology

NanoBio to receive a $4.1M subcontract for developing nanoemulsion-based mucosal vaccine adjuvants

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Influenza News and Research

Latest Influenza News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in